@article{bourliere:hal-01795715,
  TITLE = {{Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial}},
  AUTHOR = {Bourliere, Marc and Rabiega, Pascaline and Ganne-Carrie, Nathalie and Serfaty, Lawrence and Marcellin, Patrick and Barthe, Yoann and Thabut, Dominique and Guyader, Dominique and Hezode, Christophe and Picon, Magali and Causse, Xavier and Leroy, Vincent and Bronowicki, Jean-Pierre and Carrieri, Patrizia and Riachi, Ghassan and Rosa, Isabelle and Attali, Pierre and Molina, Jean-Michel and Bacq, Yannick and Tran, Albert and Grang{\'e}, Jean-Didier and Zoulim, Fabien and Fontaine, H{\'e}l{\`e}ne and Alric, Laurent and Bertucci, Inga and Bouvier-Alias, Magali and Carrat, F.},
  URL = {https://univ-lyon1.hal.science/hal-01795715},
  JOURNAL = {{The Lancet Gastroenterology \& Hepatology}},
  PUBLISHER = {{Elsevier}},
  VOLUME = {2},
  PAGES = {177-188},
  YEAR = {2017},
  MONTH = Mar,
  DOI = {10.1016/S2468-1253(16)30189-3},
  KEYWORDS = {therapy ; Aged ; analysis ; Carcinoma ; contraindications ; Dna ; France ; Time ; Hepatitis ; Serum ; Pregnancy ; Patients ; methods ; Medicine ; Intention to Treat Analysis ; Injections ; Hepatitis B virus ; Hepatitis B},
  PDF = {https://univ-lyon1.hal.science/hal-01795715v1/file/hal-01795715.pdf},
  HAL_ID = {hal-01795715},
  HAL_VERSION = {v1},
}